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Background: Reported prevalence of restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), varies
from country to country, and methodologic inconsistencies limit comparison of data. Impact of RLS on quality of life
and health has been studied primarily in industrialized countries, particularly Europe and the United States. Many
studies have relied exclusively on self-report of symptoms or have assessed only medical populations. Recently, interest
has emerged on the impact of WED in rural, underserved populations globally.
Methods: In a population-based survey conducted in rural Ecuador, we assessed the relationship of psychological
distress to WED, evaluated with the Depression Anxiety Stress Scales–21. WED was diagnosed through a 2-phase
method in which all residents were screened with the International Restless Legs Syndrome Study Group (IRLSSG)
questionnaire and all suspected cases were subsequently confirmed through expert medical examination. WED severity
was assessed with the IRLSSG rating scale.
Results: Of 665 persons (mean [SD] age, 59.5 [12.6] years; women, 386 [58%]), 76 had depression, 93 had anxiety, and
60 reported stress. Forty persons (6%) had WED, with 15 (38%) having severe disease. In a regression model adjusted
for age and sex, the prevalence of depression, anxiety, and stress was about 3 times greater among persons with WED
than the general population.
Conclusions: Although cross-sectional data cannot establish causation, this study shows the large behavioral health
burden associated with WED in an untreated, rural population.
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Willis-Ekbom diseaseBackground
Restless legs syndrome (RLS), also known as Willis-
Ekbom disease (WED), is an underrecognized disorder
characterized by an unpleasant urge to move the legs—
occurring most often during evening or nighttime—that
is partially or completely relieved with movement [1].
Previous studies have shown that patients with WED
have higher rates of depression or anxiety disorders than* Correspondence: castillo.pablo@mayo.edu
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unless otherwise stated.controls [2-5]. The pathogenesis of this association is
complex and probably multifactorial, and perhaps it can
be explained through the associated sleep disturbances
or shared metabolic pathway in WED [6]. Irrespective of
its cause, simultaneous occurrence of psychological dis-
tress adds substantially to the negative effects of WED
[7]. Therefore, prompt recognition and therapy for de-
pression, anxiety, or stress are mandatory to improve the
quality of life for patients with WED.
Although publications have reported data on emotional
well-being and RLS, only 3 population-based studies have
explored the mental health burden in WED through face-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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assessments [8-10].
With the exception of 3 Asian studies [3,6,11], all cur-
rently available studies reporting data on WED and psy-
chological distress were conducted in whites residing in
the United States and Europe. Therefore, additional epi-
demiologic data in persons from other ethnicities and
races are needed. Research on RLS and its mental health
burden in underserved, native populations has not been
conducted. In the present study, we investigated RLS
and the prevalence of mood disorders among a native
South American population (Amerindians).
The few population-based studies on the prevalence of
WED in Latin America have not addressed the issue of
associated psychological distress [12-15]. We previously
documented that the prevalence of WED in the rural vil-
lage of Atahualpa is 6% in residents aged 40 years and
older [16]. We conducted the present study in the same
rural village of Ecuador to assess the prevalence of self-
reported psychological distress among persons with
WED living in this underserved population. Because of
interindividual vulnerability to both WED and psycho-
logical distress, our study provides information distinct
from the findings of previous European and North
American studies, including differences in sleep environ-
ment, as well as socioeconomic and demographic char-
acteristics. This information may help to reduce the
impact of health disparities through an improved under-
standing of the contribution of ethnicity and race and
sociodemographic characteristics to WED and psycho-
logical distress.
Methods
The Atahualpa Project is a population-based study designed
to reduce the burden of neurologic diseases in rural coastal
Ecuador [17,18]. Residents of Atahualpa, Ecuador, are ra-
cially homogeneous, with more than 95% belonging to the
Mestizo ethnic group, or persons of Native American and
mixed European descent, who are also called Amerindians.
The village is located at sea level, close to the equator (lon-
gitude and latitude, 2°18’S and 80°46’W), and was selected
for this project because it is representative of the country
of Ecuador. The protocol and the informed consent form
were approved by the institutional review board of Hospital
Clínica Kennedy in Guayaquil, Ecuador (FWA 00006867).
Trained field personnel performed a door-to-door survey
directed to assess demographic characteristics of all
Atahualpa residents aged 40 years and older, defined as
persons who had lived in the community for 3 months
before June 15, 2013, the day of the survey.
For this first phase of the study, rural physicians inter-
viewed consented persons with a questionnaire directed to
identify those with suspected WED. The field instrument
used for the detection of suspected cases was developedby the International Restless Legs Syndrome Study Group
(IRLSSG) [19]. It consists of 4 questions that must be an-
swered affirmatively to create suspicion of WED. During
the second phase, a certified neurologist (O.H.D.B.) and a
sleep specialist (P.R.C.) transitorily moved to Atahualpa to
medically examine all persons who were screened because
of suspected WED, as well as a sample of age- and sex-
matched persons considered negative for WED during the
screening phase. Whether a person was considered to
have a suspected case of WED or to be a control subject
was masked to the neurologists. During this phase, per-
sons originally thought to have WED but who instead had
a condition that mimicked WED (eg, nocturnal cramps,
diabetic neuropathy) were excluded, and those with a de-
finitive diagnosis of WED were inquired about disease se-
verity through use of the IRLSSG rating scale [20]. This
scale consists of 10 questions rated on a 4-point Likert
scale, with a maximum total score of 40; a score greater
than 20 is considered a severe case of WED.
Psychological distress also was evaluated during the sur-
vey. For this phase, we used the Depression Anxiety Stress
Scales–21 (DASS-21) [21]. This scale provides quantitative
measures of depression (dysphoria, hopelessness, devalu-
ation of life, self-deprecation, lack of interest and involve-
ment, anhedonia, and inertia), anxiety (autonomic arousal,
skeletal muscle effects, situational anxiety, and subjective
experience of anxious affect) and stress (chronic nonspe-
cific psychological arousal, difficulty relaxing, nervous ten-
sion, and being easily upset, irritable, and intolerant). The
DASS-21 is a reliable and consistent field instrument con-
taining 3 sets of questions (7 questions per set) evaluating
the different axes of psychological distress. Each response
is rated on a 4-point Likert scale ranging from 0 (not at
all) to 3 (almost always) with a maximum total score of 21
for each axis.
One of the 3 field instruments used in our survey, the
questionnaire developed by IRLSSG in 2003 for detection
of suspected WED, had been previously validated in
Ecuadorian Spanish-speaking communities [13]. The
other 2 instruments—the IRLSSG rating scale and the
DASS-21—were independently translated and back-
translated from English to Spanish by bilingual neurol-
ogists from our group (O.H.D.B. and P.R.C.). Then, the
Spanish versions of both scales were culturally adapted
with the aid of Atahualpa’s community leaders and
tested in a random sample of the population before the
full survey.
Descriptive statistics are presented as mean and SD for
continuous variables and as number and percentage for
categorical variables. Statistical significance was deter-
mined with χ2 test for categorical variables and Kruskal-
Wallis test for continuous variables. Using a regression
model, we examined the association between WED and
each axis of psychological distress after adjusting for age
Table 1 Depression, anxiety, and stress in WED severity in natives and mestizos in rural coastal Ecuador
Patients, No. (%)
Characteristic of functional distress WED (n = 40) Severe WED (n = 15) Mild or moderate WED (n = 25) P value
Depression 12 (30.0) 5 (33.3) 7 (28.0) .72
Anxiety 12 (30.0) 5 (33.3) 7 (28.0) .72
Stress 9 (22.5) 3 (20.0) 6 (24.0) .77
≥2 Axes of functional distress 11 (27.5) 4 (26.7) 7 (28.0) .93
Abbreviation: WED Willis-Ekbom disease.
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formed with WED as the dependent variable. All vari-
ables were dichotomized, and the output of the model
was the odds of a given relation. We also evaluated
whether WED was more severe among persons with de-
pression, anxiety, or stress than those who did not test
positive for these axes of psychological distress. All ana-
lyses were performed using Stata software version 13
(StataCorp LP).
Results
The door-to-door survey identified 688 Atahualpa resi-
dents aged 40 years and older, of whom 23 declined par-
ticipation or could not complete the questionnaires. In
total, 665 persons (mean [SD] age, 59.5 [12.6] years;
women, 58%) were interviewed with both the IRLSSG
instrument and the DASS-21. The IRLSSG instrument
was positive in 94 persons, but neurologic evaluation
showed that only 40 had WED. None of the controls
were found to have the disease, giving a 6% prevalence
of WED (40/665) among Atahualpa residents in this
age-group. Mean (SD) age of patients with WED was
53.5 (7.8) years, and 25 (63%) of these participants were
women. Patients with WED were younger than the aver-
age age of all participants (P = .002), but the percentage
of women was not significantly different among those
with and without the disease (P = .65). No participant
had previously received a diagnosis of WED, and none
had received dopaminergic agonists or any other specific
WED therapy.
Results of the DASS-21 indicated that 76 persons had
depression, 93 had anxiety, and 60 had stress. None of
these persons had received a previous diagnosis of theseTable 2 Axes of functional distress according to WED in nativ
Pat





≥2 Axes of functional distress 66 (9.9)
Abbreviations: OR Odds ratio, WED Willis-Ekbom disease.
aRegression model, after adjustment for age and sex.conditions or had been treated with sedatives or antide-
pressants. Depressed and anxious persons were older
than those without depression or anxiety (P = .009 and
P < .001, respectively), but the prevalence of depression
and anxiety was not significantly different across men
and women. In contrast, stress was less common in
women than in men (P = .01), but its prevalence was not
influenced by age. No differences were found in the
mean age or the sex of persons who had only 1 axis of
psychological distress (n = 66) compared with those who
had 2 or 3 axes (n = 74). Fifteen (38%) of the 40 patients
with WED had a severe disease according to the IRLSSG
rating scale. The different axes of psychological distress
were not more prevalent among persons with severe
WED than those with mild to moderate WED (Table 1).
Results from the regression model, showing correl-
ation among the different axes of psychological distress
(alone or in combination) and the presence of WED, are
detailed in Table 2. Depression, anxiety, and stress, as
well as their combination, were significantly more com-
mon among persons with WED than the general popula-
tion, after adjustment for age and sex.
Discussion
The findings of this 2-phase study suggest that WED is
associated with substantial mood impairment. Our study
showed that self-reported symptoms of depression, anx-
iety, and stress occur in about one-third of persons with
WED and are about 3 times more prevalent than in the
general population. Despite these data, psychological dis-
tress was not more common among persons with severe
WED than those with mild to moderate WED. In this







OR (95% CI); P valuea
12 (30.0) 64 (10.2) 4.5 (2.2-9.7); <.001
12 (30.0) 81 (13.0) 3.6 (1.7-7.7); .001
9 (22.5) 51 (8.2) 3.3 (1.5-7.6); .004
11 (27.5) 55 (8.8) 4.3 (2.0-9.2); <.001
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among WED patients seen at a sleep clinic, irrespective
of WED severity [6]. On this basis, it may be suggested
that psychological distress, particularly depression, may
be a comorbidity in WED and probably is due to related
pathogenetic pathways (ie, dopaminergic deficiency or
serotonin alterations) [22]. However, in a door-to-door
population-based Turkish study, patients with severe
WED were more likely to have higher scores in the
Hamilton anxiety and depression scales [3]. Another
study, from Germany, also showed a positive correlation
between WED severity and psychological distress [2].
Most of the patients in that study were receiving therapy
for WED symptoms, and this finding may have been
biased for medication adverse effects.
The relation between psychological distress and WED
continues to be complex and it is likely bidirectional.
Some studies have shown that WED symptoms occur
before depression [3,5] and others have shown the con-
trary [23]. Yet, by causing sleep loss, the sensory motor
discomfort of WED could be the cause of psychological
distress [24].
Antidepressants can exacerbate WED symptoms, and
medications used for WED (ie, dopaminergic drugs) may
have a role in the development of depression and anx-
iety. Our survey participants had not been treated with
either antidepressants or dopaminergic drugs; therefore,
our findings were not influenced by medication use. The
medication-naïve nature of the population, as well as the
population-based design of our study, argues for the
strength of our results. However, a potential weakness is
the cross-sectional method of the survey, precluding as-
sessment of causality. Further longitudinal studies in
these underserved populations are warranted to deter-
mine whether 1) psychological distress precedes WED
symptoms, 2) WED symptoms influence the occurrence
of depression or anxiety, and 3) both conditions are co-
morbidities sharing similar pathogenetic mechanisms.
Conclusions
The results of the present study are suggestive that the
mental health burden of WED is considerable, and more
data on the cause-and-effect relation of this association
are needed for planning a rational therapy that improves
the psychological burden of affected persons.
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